Radiation instead of surgery? new trial for elderly breast cancer patients
NCT ID NCT06523894
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a precise, high-dose radiation technique called SBRT as an alternative to surgery for breast cancer in patients over 70 who are too frail for an operation. The goal is to find the safest highest dose that can be given in one to five sessions. If it works, it could offer a less invasive option for those who cannot have surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stereotactic body radiotherapy (SBRT) – high-precision radiation
What this could lead to
If successful, this could offer a non-surgical treatment option for elderly or frail breast cancer patients who cannot undergo surgery.
What could go wrong
This is an early-phase trial with only 36 participants, so it is too small to prove effectiveness. The main goal is to find a safe dose, not to confirm that the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radiation Oncology Department, Geneva University Hospital
RECRUITINGGeneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••